Physician profile
Michael S Fleischer
NPI 1730160102
$7,589.93
in general payments reported to CMS, 2019-2025
28 companies · $1,207 in 2025
The $1,207 reported for 2025 was more than what 85% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $700 · 2020: $563 · 2021: $915 · 2022: $2,133 · 2023: $1,156 · 2024: $916 · 2025: $1,207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,194 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,194.18 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $1,673.77 | 2021-2025 | |
| Scynexis, INC. | $1,157.23 | 2022 | |
| Abbvie INC. | $1,120.94 | 2019-2025 | |
| Therapeuticsmd, INC. | $741.78 | 2019-2022 | |
| Organon LLC | $669.93 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $451.81 | 2021-2025 | Summit Doppler, Paragard T 380a |
| Astellas Pharma US INC | $319.32 | 2023-2025 | Veozah |
| Heron Therapeutics, INC. | $124.46 | 2025 | Zynrelef, Aponvie |
| Sumitomo Pharma America, INC. | $120.65 | 2023 | Myfembree |
| Amag Pharmaceuticals, INC. | $118.57 | 2019 | |
| Biogen, INC. | $117.89 | 2025 | Zurzuvae |
| Allergan, INC. | $114.54 | 2019-2020 | |
| Virtus Pharmaceuticals LLC | $102.75 | 2021-2022 | |
| Baxter Healthcare | $102.17 | 2025 | Perclot |
| Radiometer America, INC | $101.78 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medicem INC. | $99.73 | 2021 | |
| Hologic Sales and Service, LLC | $74.54 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Lupin INC. | $52.75 | 2019-2020 | |
| Aspira Women'S Health INC | $51.36 | 2019-2020 | |
| Myovant Sciences INC. | $43.68 | 2021-2022 | |
| Avion Pharmaceuticals | $42.67 | 2020-2022 | |
| Exeltis, USA INC. | $36.40 | 2021-2024 | Slynd |
| Millicent US INC | $34.84 | 2019-2025 | Femlyv |
| Agile Therapeutics, INC. | $28.07 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.38 | 2019 | |
| Mallinckrodt Hospital Products INC. | $23.43 | 2020 | |
| Alydia Health | $23.14 | 2021 | |
| Shield Therapeutics INC | $17.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Fleischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.